Logo image of ZJK

ZJK INDUSTRIAL CO LTD (ZJK) Stock Fundamental Analysis

NASDAQ:ZJK - Nasdaq - KYG98Y9E1025 - Common Stock - Currency: USD

5  -0.4 (-7.41%)

After market: 4.8 -0.2 (-4%)

Fundamental Rating

5

ZJK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. While ZJK has a great health rating, its profitability is only average at the moment. ZJK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ZJK was profitable.
In the past year ZJK had a positive cash flow from operations.
ZJK Yearly Net Income VS EBIT VS OCF VS FCFZJK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M 4M 6M

1.2 Ratios

With an excellent Return On Assets value of 16.33%, ZJK belongs to the best of the industry, outperforming 95.31% of the companies in the same industry.
With an excellent Return On Equity value of 30.33%, ZJK belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
ZJK's Return On Invested Capital of 14.93% is amongst the best of the industry. ZJK outperforms 87.50% of its industry peers.
ZJK had an Average Return On Invested Capital over the past 3 years of 18.00%. This is significantly above the industry average of 10.67%.
Industry RankSector Rank
ROA 16.33%
ROE 30.33%
ROIC 14.93%
ROA(3y)16.46%
ROA(5y)N/A
ROE(3y)32.67%
ROE(5y)N/A
ROIC(3y)18%
ROIC(5y)N/A
ZJK Yearly ROA, ROE, ROICZJK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

With an excellent Profit Margin value of 16.86%, ZJK belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
ZJK's Profit Margin has declined in the last couple of years.
ZJK has a better Operating Margin (12.06%) than 60.94% of its industry peers.
ZJK's Operating Margin has declined in the last couple of years.
ZJK's Gross Margin of 39.09% is fine compared to the rest of the industry. ZJK outperforms 71.88% of its industry peers.
ZJK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.06%
PM (TTM) 16.86%
GM 39.09%
OM growth 3Y-34.14%
OM growth 5YN/A
PM growth 3Y-17.12%
PM growth 5YN/A
GM growth 3Y5.68%
GM growth 5YN/A
ZJK Yearly Profit, Operating, Gross MarginsZJK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ZJK is creating value.
ZJK has less shares outstanding than it did 1 year ago.
ZJK has a worse debt/assets ratio than last year.
ZJK Yearly Shares OutstandingZJK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
ZJK Yearly Total Debt VS Total AssetsZJK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 9.55 indicates that ZJK is not in any danger for bankruptcy at the moment.
The Altman-Z score of ZJK (9.55) is better than 94.53% of its industry peers.
ZJK has a debt to FCF ratio of 1.11. This is a very positive value and a sign of high solvency as it would only need 1.11 years to pay back of all of its debts.
ZJK's Debt to FCF ratio of 1.11 is amongst the best of the industry. ZJK outperforms 83.59% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that ZJK is not too dependend on debt financing.
ZJK's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. ZJK outperforms 77.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.11
Altman-Z 9.55
ROIC/WACC1.8
WACC8.31%
ZJK Yearly LT Debt VS Equity VS FCFZJK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.81 indicates that ZJK should not have too much problems paying its short term obligations.
The Current ratio of ZJK (1.81) is worse than 60.94% of its industry peers.
A Quick Ratio of 1.51 indicates that ZJK should not have too much problems paying its short term obligations.
ZJK's Quick ratio of 1.51 is fine compared to the rest of the industry. ZJK outperforms 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.51
ZJK Yearly Current Assets VS Current LiabilitesZJK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

4

3. Growth

3.1 Past

The earnings per share for ZJK have decreased strongly by -11.16% in the last year.
ZJK shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.65% yearly.
ZJK shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.56%.
ZJK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.28% yearly.
EPS 1Y (TTM)-11.16%
EPS 3Y7.65%
EPS 5YN/A
EPS Q2Q%-51.43%
Revenue 1Y (TTM)40.56%
Revenue growth 3Y29.28%
Revenue growth 5YN/A
Sales Q2Q%30.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZJK Yearly Revenue VS EstimatesZJK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 33.33, ZJK can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ZJK is valued a bit more expensive than 64.84% of the companies in the same industry.
ZJK is valuated rather expensively when we compare the Price/Earnings ratio to 26.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.33
Fwd PE N/A
ZJK Price Earnings VS Forward Price EarningsZJK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ZJK's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ZJK is more expensive than 75.00% of the companies in the same industry.
70.31% of the companies in the same industry are cheaper than ZJK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 108.59
EV/EBITDA 39.23
ZJK Per share dataZJK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

The decent profitability rating of ZJK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZJK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZJK INDUSTRIAL CO LTD

NASDAQ:ZJK (6/6/2025, 8:00:02 PM)

After market: 4.8 -0.2 (-4%)

5

-0.4 (-7.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-28 2025-04-28
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap306.90M
AnalystsN/A
Price TargetN/A
Short Float %1.74%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 33.33
Fwd PE N/A
P/S 5.68
P/FCF 108.59
P/OCF 57.44
P/B 10.22
P/tB 10.23
EV/EBITDA 39.23
EPS(TTM)0.15
EY3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY0.92%
OCF(TTM)0.09
OCFY1.74%
SpS0.88
BVpS0.49
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.33%
ROE 30.33%
ROCE 20.5%
ROIC 14.93%
ROICexc 25.93%
ROICexgc 25.98%
OM 12.06%
PM (TTM) 16.86%
GM 39.09%
FCFM 5.23%
ROA(3y)16.46%
ROA(5y)N/A
ROE(3y)32.67%
ROE(5y)N/A
ROIC(3y)18%
ROIC(5y)N/A
ROICexc(3y)20.57%
ROICexc(5y)N/A
ROICexgc(3y)20.57%
ROICexgc(5y)N/A
ROCE(3y)23.38%
ROCE(5y)N/A
ROICexcg growth 3Y-31.53%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.57%
ROICexc growth 5YN/A
OM growth 3Y-34.14%
OM growth 5YN/A
PM growth 3Y-17.12%
PM growth 5YN/A
GM growth 3Y5.68%
GM growth 5YN/A
F-Score4
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.11
Debt/EBITDA 0.42
Cap/Depr 291.09%
Cap/Sales 4.66%
Interest Coverage 794.66
Cash Conversion 72.38%
Profit Quality 31.02%
Current Ratio 1.81
Quick Ratio 1.51
Altman-Z 9.55
F-Score4
WACC8.31%
ROIC/WACC1.8
Cap/Depr(3y)205.96%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.16%
EPS 3Y7.65%
EPS 5YN/A
EPS Q2Q%-51.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.56%
Revenue growth 3Y29.28%
Revenue growth 5YN/A
Sales Q2Q%30.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.06%
EBIT growth 3Y-14.85%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.79%
OCF growth 3Y31.27%
OCF growth 5YN/A